Pretreatment expression of miR-191a may predict response to the induction chemotherapy based on cytarabine in acute myeloid leukemia patients - a single-center pilotal study.
<h4>Background</h4>Acute myeloid leukemia (AML) is associated with the accumulation of acquired genetic disorders. Moreorver chromosomal and molecular changes are independent prognostic factors that are taken into account to determine prognosis and treatment. MicroRNAs are novel gene reg...
Saved in:
| Main Authors: | Agnieszka Szymczyk, Sylwia Chocholska, Katarzyna Radko, Marek Hus, Monika Podhorecka |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0324320 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pretreatment expression of miR-191a may predict response to the induction chemotherapy based on cytarabine in acute myeloid leukemia patients – a single-center pilotal study
by: Agnieszka Szymczyk, et al.
Published: (2025-01-01) -
LOW DOSE CYTARABINE PLUS SORAFENIB IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA
by: Tural Mahmudov
Published: (2025-07-01) -
Metabolic reprogramming by PRDM16 drives cytarabine resistance in acute myeloid leukemia
by: Junji Ikeda, et al.
Published: (2025-06-01) -
Low Dose Cytarabine and Cladribine for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: Clinical Experience
by: SV Gritsaev, et al.
Published: (2016-01-01) -
Bilosomes and Niosomes for Enhanced Intestinal Absorption and In Vivo Efficacy of Cytarabine in Treatment of Acute Myeloid Leukemia
by: Abdelrahman R. Said, et al.
Published: (2024-11-01)